Sector 10, Inc. (SECI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | - USD | -15.5% |
| 2022 | - USD | -101.65% |
| 2021 | 2.11 Million USD | 350.8% |
| 2020 | -832.1 Thousand USD | -0.01% |
| 2019 | -832.02 Thousand USD | -3.93% |
| 2018 | -800.57 Thousand USD | 6.34% |
| 2017 | -854.78 Thousand USD | -3.18% |
| 2016 | -828.44 Thousand USD | -1.55% |
| 2015 | -815.83 Thousand USD | -5.78% |
| 2014 | -771.26 Thousand USD | 2.93% |
| 2013 | -794.56 Thousand USD | 0.66% |
| 2012 | -1.29 Million USD | 56.68% |
| 2011 | -2.27 Million USD | 57.21% |
| 2010 | -4.53 Million USD | -321.97% |
| 2009 | -505.39 Thousand USD | -760.25% |
| 2008 | -118.87 Thousand USD | 3.5% |
| 2007 | -123.18 Thousand USD | 89.76% |
| 2006 | -1.2 Million USD | 19.76% |
| 2005 | -1.49 Million USD | -75.56% |
| 2004 | -854.28 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -3400.00 USD | -105.07% |
| 2024 Q2 | -1658.00 USD | -223.83% |
| 2024 Q1 | -512.00 USD | 98.47% |
| 2023 Q2 | -3008.00 USD | -82.86% |
| 2023 Q3 | -1658.00 USD | 44.88% |
| 2023 Q4 | -33.53 Thousand USD | -1922.5% |
| 2023 FY | - USD | -15.5% |
| 2023 Q1 | -1645.00 USD | 78.39% |
| 2022 Q4 | -7612.00 USD | -5.66% |
| 2022 Q1 | -11.18 Thousand USD | -100.53% |
| 2022 Q2 | -8498.00 USD | 24.02% |
| 2022 FY | - USD | -101.65% |
| 2022 Q3 | -7204.00 USD | 15.23% |
| 2021 FY | - USD | 350.8% |
| 2021 Q1 | -204.62 Thousand USD | 11.38% |
| 2021 Q2 | -176.95 Thousand USD | 13.53% |
| 2021 Q3 | -6575.00 USD | 96.28% |
| 2021 Q4 | 2.12 Million USD | 32361.41% |
| 2020 Q1 | -207.91 Thousand USD | 0.33% |
| 2020 Q4 | -230.89 Thousand USD | -16.37% |
| 2020 Q3 | -198.42 Thousand USD | -1.82% |
| 2020 FY | - USD | -0.01% |
| 2020 Q2 | -194.87 Thousand USD | 6.27% |
| 2019 Q1 | -205.98 Thousand USD | -0.13% |
| 2019 FY | - USD | -3.93% |
| 2019 Q4 | -208.61 Thousand USD | -0.29% |
| 2019 Q3 | -208 Thousand USD | 0.67% |
| 2019 Q2 | -209.41 Thousand USD | -1.67% |
| 2018 Q1 | -197.82 Thousand USD | 4.84% |
| 2018 FY | - USD | 6.34% |
| 2018 Q4 | -205.72 Thousand USD | -3.99% |
| 2018 Q3 | -197.82 Thousand USD | 0.7% |
| 2018 Q2 | -199.21 Thousand USD | -0.71% |
| 2017 Q1 | -188.5 Thousand USD | 9.69% |
| 2017 FY | - USD | -3.18% |
| 2017 Q4 | -207.89 Thousand USD | 13.38% |
| 2017 Q3 | -240 Thousand USD | -9.89% |
| 2017 Q2 | -218.39 Thousand USD | -15.86% |
| 2016 FY | - USD | -1.55% |
| 2016 Q3 | -205.54 Thousand USD | 1.37% |
| 2016 Q2 | -208.39 Thousand USD | -1.28% |
| 2016 Q4 | -208.73 Thousand USD | -1.55% |
| 2016 Q1 | -205.76 Thousand USD | 1.84% |
| 2015 Q4 | -209.62 Thousand USD | -11.45% |
| 2015 Q2 | -210.01 Thousand USD | -0.92% |
| 2015 FY | - USD | -5.78% |
| 2015 Q1 | -208.09 Thousand USD | -3.85% |
| 2015 Q3 | -188.09 Thousand USD | 10.44% |
| 2014 Q1 | -193.46 Thousand USD | 7.56% |
| 2014 FY | - USD | 2.93% |
| 2014 Q2 | -182.36 Thousand USD | 5.74% |
| 2014 Q3 | -195.05 Thousand USD | -6.96% |
| 2014 Q4 | -200.38 Thousand USD | -2.73% |
| 2013 FY | - USD | 0.66% |
| 2013 Q4 | -209.27 Thousand USD | 7.61% |
| 2013 Q3 | -226.5 Thousand USD | -8.11% |
| 2013 Q2 | -209.5 Thousand USD | -40.34% |
| 2013 Q1 | -149.28 Thousand USD | 81.41% |
| 2012 Q1 | -211.38 Thousand USD | 90.72% |
| 2012 FY | - USD | 56.68% |
| 2012 Q4 | -802.99 Thousand USD | -489.26% |
| 2012 Q3 | -136.27 Thousand USD | 8.65% |
| 2012 Q2 | -149.17 Thousand USD | 29.43% |
| 2011 FY | - USD | 57.21% |
| 2011 Q4 | -2.27 Million USD | -204916.46% |
| 2011 Q3 | 1112.00 USD | 100.22% |
| 2011 Q2 | -511.02 Thousand USD | -77.79% |
| 2011 Q1 | -287.42 Thousand USD | 90.96% |
| 2010 Q4 | -3.17 Million USD | -667.2% |
| 2010 FY | - USD | -321.97% |
| 2010 Q1 | -411.22 Thousand USD | -1864.48% |
| 2010 Q2 | -311.19 Thousand USD | 24.33% |
| 2010 Q3 | -414.28 Thousand USD | -33.13% |
| 2009 Q2 | -129.51 Thousand USD | 89.83% |
| 2009 Q3 | -115.92 Thousand USD | 10.5% |
| 2009 FY | - USD | -760.25% |
| 2009 Q4 | -20.93 Thousand USD | 81.94% |
| 2009 Q1 | -1.27 Million USD | -1977.83% |
| 2008 Q1 | 150.28 Thousand USD | 18.95% |
| 2008 FY | - USD | 3.5% |
| 2008 Q4 | -61.28 Thousand USD | -4.15% |
| 2008 Q3 | -58.84 Thousand USD | -138.93% |
| 2008 Q2 | 151.14 Thousand USD | 0.57% |
| 2007 Q2 | -614.7 Thousand USD | -51.86% |
| 2007 Q4 | 126.33 Thousand USD | -83.68% |
| 2007 FY | - USD | 89.76% |
| 2007 Q1 | -404.78 Thousand USD | -110.85% |
| 2007 Q3 | 774.27 Thousand USD | 225.96% |
| 2006 FY | - USD | 19.76% |
| 2006 Q4 | -191.97 Thousand USD | 24.87% |
| 2006 Q3 | -255.53 Thousand USD | 17.73% |
| 2006 Q2 | -310.61 Thousand USD | -84.78% |
| 2006 Q1 | -168.09 Thousand USD | 52.71% |
| 2005 Q2 | -430.58 Thousand USD | -30.3% |
| 2005 FY | - USD | -75.56% |
| 2005 Q1 | -330.45 Thousand USD | 61.55% |
| 2005 Q4 | -355.44 Thousand USD | 7.15% |
| 2005 Q3 | -382.82 Thousand USD | 11.09% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | -859.5 Thousand USD | -15978.46% |
| 2004 Q2 | -257.26 Thousand USD | -11208.31% |
| 2004 Q3 | 5413.00 USD | 102.1% |
| 2004 Q1 | -2275.00 USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 100.0% |
| Ansell Limited | 209.86 Million USD | 100.0% |
| Ansell Limited | 206.3 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 42.83 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | -1.62 Million USD | 100.0% |
| Psykey, Inc. | -1.29 Million USD | 100.0% |
| ConvaTec Group Plc | 455.5 Million USD | 100.0% |
| ConvaTec Group Plc | 455.5 Million USD | 100.0% |
| Encision Inc. | -544.19 Thousand USD | 100.0% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 100.0% |
| Innovative MedTech Inc. | -7.67 Million USD | 100.0% |
| LifePoint, Inc. | -14.2 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -215.23 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | -186.13 Million USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.0% |
| SheerVision, Inc. | -110.53 Thousand USD | 100.0% |
| United Health Products, Inc. | -2.5 Million USD | 100.0% |
| Vasamed, Inc. | -4.57 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 100.0% |
| Yubo International Biotech Limited | -1.17 Million USD | 100.0% |